What is Molecular Instruments?
Molecular Instruments, Inc. is at the forefront of developing sophisticated imaging solutions for in situ hybridization (ISH) and immunofluorescence (IF). Their proprietary HCR RNA-FISH/IF technology enables simultaneous, quantitative, and high-resolution imaging of RNA and proteins within intact tissues. The HCR HiFi Encoder further simplifies multiplex immunofluorescence by integrating with standard primary antibodies, offering a streamlined workflow. The company also provides enzyme-free signal amplification, such as HCR Gold RNA-FISH, ensuring high sensitivity for diverse research targets. Their innovations are crucial for researchers in molecular biology and tissue analysis seeking deeper insights into cellular mechanisms.
How much funding has Molecular Instruments raised?
Molecular Instruments has raised a total of $127K across 1 funding round:
Debt
$127K
Debt (2021): $127K with participation from PPP
What's next for Molecular Instruments?
With a substantial late-stage funding context, Molecular Instruments is strategically positioned for accelerated growth and market expansion. The recent major strategic investment suggests confidence from backers in the company's technology and its potential to capture a larger share of the advanced imaging market. Future developments are likely to focus on scaling production, enhancing product capabilities, and broadening the application of their multiplex imaging solutions across various research and diagnostic sectors. This capital infusion will be instrumental in driving innovation and solidifying their leadership in high-resolution molecular imaging.
See full Molecular Instruments company page
